Orexigen Therapeutics Obtains $60,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=96db5751-b608-4e10-9a34-df2d857a75e5
Date
9/16/2015
Company Name
Orexigen Therapeutics
Mailing Address
3344 N. Torrey Pines Court La Jolla, CA 92037 USA
Company Description
OREXIGEN is studying a novel, and potentially more effective way, to achieve and sustain weight loss through a combined, two-drug approach.
Website
http://www.orexigen.com
Transaction Type
Venture Equity
Transaction Amount
$60,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
M&A Terms
Venture Investor
Undisclosed